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Abstract
Background: The pathogenesis of glioblastoma is complex, and the implicated molecular mechanisms are yet to
be understood. There are scattered reports describing a possible relationship between meningioma and glioblastoma
and more rarely a relationship between infarction and glioblastoma.
Case presentation: We are reporting a 32-year-old male who developed left middle cerebral artery (MCA) infarction
as a surgical complication for sphenoid meningioma. He developed recurrent symptoms 4 months later due to
development of a glioblastoma adjacent to both the territory of the prior MCA infarct and the residual meningioma.
Conclusions: This case adds further contribution to the literature of the possible pathological association between
glioblastoma and brain infarction on a background of meningioma.
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Background
Several authors have reported the development of glio-
blastoma in areas of reactive gliosis [1]. Others have
described both synchronously and, less commonly, asyn-
chronously presenting meningioma and glioblastoma
[2–4]. Studies on the relationship between glioma and
traumatic brain injury have been conducted [5, 6].
Furthermore, there are very few reports relating
strokes to glioblastoma, and most of them describe in-
farctions secondary to glioblastoma [7, 8], while the de-
velopment of glioblastoma in the territories of previous
cerebral infarctions has been rarely reported [1, 9]. Many
hypotheses have been suggested to explain these obser-
vations, yet they remain speculative in nature and the
glioblastoma developmental process is still obscure and
not clearly understood [1–3]. We discuss two possible
theories of glioblastoma development in such cases: first
is the pathogenic mechanism of coexisted glioblastoma
and meningioma and second is the development of glio-
blastoma secondary to the middle cerebral artery (MCA)
infarct. The uncovering of the mechanisms that led to
the phenomena mentioned above could further our
knowledge regarding the pathogenesis of glioblastoma
and subsequently their management.
We are reporting a 32-year-old male who underwent
surgical resection of a left sphenoid meningioma that
was complicated by an iatrogenic injury of the MCA
with subsequent infarction. The patient had a remark-
able recovery from the stroke but deteriorated 6 months
later; radiological and histopathological examination re-
vealed that he developed a glioblastoma in the territory
of the previous infarction. The literature concerning
glioblastoma developmental process is reviewed.
Case presentation
A 32-year-old male first presented in January 2010 with
a progressive headache for a 4-month duration. He was
investigated with computed tomography (CT) and mag-
netic resonance imaging (MRI) scans that revealed large
left sphenoid wing meningioma. He underwent left
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frontal craniotomy in a hospital at a neighboring country,
for resection of the sphenoid wing meningioma. Brain
swelling complicated the attempt of tumor resection; as a
result, surgery was terminated after partial resection of the
tumor. The patient had a complicated postoperative
course with development of left middle cerebral artery is-
chemia causing aphasia and right dense hemiplegia. He
was transferred to King Abdulaziz University hospital
3 weeks after surgery for further management. The path-
ology report from his referring hospital revealed that the
tumor specimen of what has been resected was consistent
with WHO grade I meningioma. On admission, he was
conscious and alert but with marked expressive aphasia,
upper motor right facial weakness, and power of grade 2
right-side hemiparesis. Routine laboratory investigation,
including hematology, electrolytes, and renal and coagula-
tion profiles, were within normal limits. MRI scans of the
brain revealed significant residual meningioma of the left
sphenoid wing meningioma (Fig. 1). There was a left cere-
bral infarction demonstrated on the fluid-attenuated in-
version recovery (FLAIR) MRI scans (Fig. 2). The MCA
was partially narrowed at the bifurcation; there was still
significant tumor blood supply from the middle meningeal
artery (Fig. 3). The patient was evaluated by the neurology
team who started him on antiplatelet medication (aspirin,
80 mg daily) and advised delaying surgery 8–12 weeks to
allow further recovery from stroke. He was transferred to
the rehabilitation center where he received an extensive
speech and physical therapy for 3 months with subsequent
significant neurological improvement. He remained with
only mild right-hand weakness of grade 3, and subtle
word-finding difficulty, and an elective admission was
planned for resection of the residual meningioma.
His second presentation to the emergency department,
3 weeks prior his scheduled admission, was with pro-
gressive headache over 2 weeks. He was confused with
Fig. 1 Post-contrast parasagittal (a), coronal (b), and axial (c, d) MRI scans performed 3 weeks after left frontal-temporal craniotomy demonstrating
significant residual enhancing left sphenoid wing meningioma and ischemic changes in the left MCA territory
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worsened speech and right hemiparesis. Brain MRI scan
revealed unchanged size of the residual meningioma and
the previous infarction, but there were new enhancing
multi-focal and multi-centric deep frontotemporal le-
sions within and adjacent to the infarcted region and ad-
jacent to the residual meningioma (Fig. 4). The extent of
the edema and the new tumor infiltration was demon-
strated by FLAIR MRI scan which involved the left
hemisphere and extended to the right side as well
(Fig. 5). The patient was admitted and started on ste-
roids and had a stereotactic biopsy of the enhancing part
of the new frontal lobe lesions.
Histopathological examination
H & E stain revealed a highly cellular malignant glial
neoplasm with endothelial proliferation and geographical
and pseudopalisading necrosis; findings are consistent
with glioblastoma (Fig. 6). There were marked mitotic
figures which were apparent. The neoplastic cells are
embedded in thickened fibrillary stroma, the latter
highlighted with glial acidic fibrillary protein (GFAP)
(Fig. 7). Tumor cells are positive for P53 (Fig. 8) and iso-
citrate dehydrogenase (IDH-1) (Fig. 9) immunolabelings.
Tumor cells were found to be negative for reticulin and
epithelial membrane antigen (EMA). The Ki-67 prolifer-
ative index is estimated to be 5–10 % in focal areas
(Fig. 10).
The patient had an uneventful postoperative course;
he and his family declined any adjuvant chemotherapy
and radiotherapy and received palliative care at a re-
habilitation center. He died 10 weeks later due to pro-
gression of the disease. No postmortem autopsy has
been performed.
Discussion
The development of two or more distinct types of brain
tumors is a rare phenomenon associated mostly with ra-
diation exposure or phakomatosis [10, 11]. However,
there are scattered reports describing the co-occurrence
of two or more histologically different tumors in patients
who were not exposed to radiation, nor had phakomato-
sis [2, 12, 13]. The most commonly reported association
is the co-occurrence of meningioma and glioblastoma
[2]. The majority of these reports describe a collision
where the two tumors co-exist in a single primary lesion
or close proximity [2, 13], while cases where the two tu-
mors are located in totally different sites are less fre-
quently reported [14, 15].
Some authors have attributed this co-existence to
mere chance [12, 14] giving that meningioma and glio-
blastoma together account for approximately 51 % of all
primary central nervous system tumors. The develop-
ment of a glioblastoma following the total resection of a
meningioma has only been reported twice in the litera-
ture [3, 4]. Despite several authors having concluded
that this phenomenon was most likely a random statis-
tical coincidence, their different proposed theories have
been described in the literatures. Single transduction
pathway dysfunction may play an important role in the
tumorigenesis of adjacent double tumor. It has been
Fig. 2 The extent of the infarction was demonstrated by FLAIR
MRI sequence
Fig. 3 MR angiographic scan reveled marked decreased flow in the
left MCA (arrow) and prominent tumor supply from the middle
meningeal artery (arrowhead)
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found that the expression of epidermal growth factor re-
ceptor (EGFR), platelet-derived growth factor receptor
(PDGFR), and vascular endothelial growth factor (VEGF)
are involved in this mechanism [16]. Overexpression of
EGFR (ErbB1) correlates with enhanced malignant po-
tential of many human tumor types including glioblast-
oma. The EGFR family of the tyrosine kinase receptor
plays an important role in a wide variety of tumors [17].
EGFR family consists of four receptors: (ErbB1/HER),
ErbB2 (HER2/neu), ErbB3 (HER3), and ErbB4 (HER4).
When the EGFR family members are activated by other
ligands, intracellular signaling pathways are triggered
which regulate cell division [17]. EGFR family members
(EGFR, ErbB2–4) have been evaluated concomitantly in
glioma and meningioma. EGFR expression has been re-
ported in 20 % of benign meningioma [17]. The protein
expression of the different EGFR family members was
predominantly seen in tumor cells in both glioma and
meningioma, except for ErbB2. This latter observation
could indicate that ErbB2 is involved in tumor angiogen-
esis of different brain tumors [18].
Furthermore, the P53 pathway dysfunction is generally
regarded as keys cause of both glioblastoma and grade I
meningioma. Both are found in Li-Fraumeni syndrome.
Coincidence as mentioned above has been reported as a
reasonable explanation [3, 12, 14]. Another hypothesis is
that brain scar created during the operation for the first
lesion could have led to the development of glioblastoma
[4]. This process is found in areas where tissue repair
occurs. The analysis showed that PDGF receptor was
overexpressed in both tumors, thereby indicating the
oncogenic effects of activated signaling of these recep-
tors. The PDGF-mediated paracrine may induce one
tumor from another [16]. Patients with severe head
injury were reported to have increased the risk for
developing glioma [19]. The fact that the vast
Fig. 4 MRI study performed 5 months from the first surgery. Post-contrast parasagittal (a), coronal (b), and axial (c, d) MRI scans were performed
demonstrating no change in the size of the meningioma, but there are multiple ring enhancing lesions in the medial temporal lobe adjacent to
the meningioma, and in the infarcted tissue involving the corpus callosum
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majority of head trauma patients do not develop gli-
oma suggests that there must be other predisposing
factors involved [6].
A few cases of acute ischemic infarction as the first
presentation of glioblastoma have been documented in
the literature [7, 8]. In a case series done by Morgen-
stern et al., the authors have reported that 4.9 % of brain
tumor cases were initially misdiagnosed as strokes; over
half of these, misdiagnosed cases were glioblastoma [18],
while three similar cases to ours where the glioblastoma
developed in the territory of previous infarction has only
been reported [1, 9, 20]. One report described a patient
who developed a glioblastoma 2 years following an
MCA ischemic infarction [1]. The second one reported
an elderly patient who developed a glioblastoma in the
territory of a previous hemorrhagic infarction [9].
López-González et al. reported a case where a patient
developed a glioblastoma 7 months following an ische-
mic stroke [20]. The authors, in this case, have specu-
lated that a subclinical glioblastoma has caused the
ischemic injury. This explanation is unlikely in the
former two cases, especially when considering that un-
treated glioblastoma has a median survival rate of
3 months [1, 9].
Our case presents a unique situation where the pa-
tient developed a glioblastoma on the background of
a residual meningioma and an ischemic infarction. To
our knowledge, this is the first report describing such
Fig. 6 Microphotography of the biopsy specimen revealed highly
cellular malignant glial neoplasm, embedded in glial fibrillary
background, with mitosis, endothelial proliferation, and necrosis;
findings are consistent with glioblastoma (hematoxylin-eosin stain,
×40 magnifications)
Fig. 7 Tumor cells are highlighted with glial acidic fibrillary protein
staining (×40)
Fig. 8 Immunohistochemical staining positive for P53 protein (×40)
Fig. 5 The extent of the new lesions in the left hemisphere (frontal,
temporal, parietal region) was demonstrated by FLAIR MRI sequence
with subependymal infiltration crossing to the right hemisphere
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a case, and we postulate, as Zhang et al. have hypoth-
esized, that the development of meningioma and gli-
oma collision tumor is a dynamic process, where one
type occurs after the other [13]. Our case together
with other reported cases where the two tumors have
not appeared at the same time might add further sup-
port to this hypothesis of dynamic development [2,
4]. Another factor that could have contributed to the
occurrence of the glioblastoma in our patient is the
post-infarction tissue repair cascade (post-infarct tis-
sue repair defect). Recent evidence has established
parallels between brain tissue repair mechanisms and
tumorigenesis [21], in which we postulate that astro-
gliosis secondary to brain ischemia and genetic muta-
tions may have increased the chance of malignant
transformation of glial cells into glioblastoma.
Conclusions
We have presented a rare and first case where glioblast-
oma has developed on the background of a residual
meningioma and an ischemic infarction. The fact that
the vast majority of ischemic stroke patients and those
diagnosed with meningioma do not develop glioblast-
oma makes it obvious that the underlying pathogenic
mechanisms are a lot more complex and multi-factorial
than the stated malignant transformation theory.
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